Alpine Woods Capital Investors’s Teva Pharmaceuticals TEVA Stock Holding History

Alpine Woods Capital Investors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25M	Buy	36,992 +7,568	+26%	+$252K	0.27%	84
2026 Q1	$886K	Buy	29,424 +14,587	+98%	+$469K	0.21%	91
2025 Q4	$463K	Buy	+14,837	New	+$366K	0.11%	131
2017 Q4	–	Sell	-70,950	Closed	-$1.25M	–	468
2017 Q3	$1.25M	Sell	70,950 -784	-1%	-$17.6K	0.06%	231
2017 Q2	$2.38M	Hold	71,734	–	–	0.13%	160
2017 Q1	$2.3M	Sell	71,734 -219,885	-75%	-$7.5M	0.12%	164
2016 Q4	$10.6M	Sell	291,619 -22,309	-7%	-$891K	0.58%	62
2016 Q3	$14.4M	Sell	313,928 -11,099	-3%	-$579K	0.8%	37
2016 Q2	$16.3M	Sell	325,027 -65,000	-17%	-$3.46M	0.98%	21
2016 Q1	$20.9M	Buy	390,027 +56,400	+17%	+$3.31M	1.21%	10
2015 Q4	$21.9M	Buy	333,627 +17,200	+5%	+$1.06M	1.18%	9
2015 Q3	$17.9M	Sell	316,427 -90,000	-22%	-$5.84M	0.97%	17
2015 Q2	$24M	Buy	406,427 +5,900	+1%	+$364K	1.23%	10
2015 Q1	$25M	Sell	400,527 -3,200	-0.8%	-$186K	1.27%	8
2014 Q4	$23.2M	Buy	403,727 +55,100	+16%	+$3.07M	1.19%	12
2014 Q3	$18.7M	Buy	348,627 +265,402	+319%	+$14.1M	1%	26
2014 Q2	$4.37M	Hold	83,225	–	–	0.11%	111
2014 Q1	$4.4M	Buy	83,225 +21,200	+34%	+$980K	0.24%	103
2013 Q4	$2.49M	Sell	62,025 -3,700	-6%	-$146K	0.14%	135
2013 Q3	$2.48M	Sell	65,725 -1,500	-2%	-$58.5K	0.15%	125
2013 Q2	$2.63M	Buy	+67,225	New	+$2.62M	0.17%	115

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Alpine Woods Capital Investors's TEVA Position: Q2 2026 in Review

Alpine Woods Capital Investors increased its Teva Pharmaceuticals (TEVA) stake by 26% in Q2 2026, buying an estimated $252K and bringing the position to 36,992 shares worth $1.25M. The position accounts for 0.27% of the portfolio, ranked #84.

Alpine Woods Capital Investors first reported a position in TEVA in Q2 2013 and has held it in 21 quarters since. The position peaked at $25M in Q1 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Alpine Woods Capital Investors held 36,992 shares of Teva Pharmaceuticals worth $1.25M as of Q2 2026.
Alpine Woods Capital Investors bought 7,568 Teva Pharmaceuticals shares in Q2 2026, an estimated $252K.
Teva Pharmaceuticals made up 0.27% of Alpine Woods Capital Investors's portfolio in Q2 2026, its #84 holding.
Alpine Woods Capital Investors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 21 quarters since.
Alpine Woods Capital Investors's Teva Pharmaceuticals position peaked at $25M in Q1 2015.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Alpine Woods Capital Investors's 13F filing for Q2 2026, filed 7 Aug 2026.